MeiraGTx Holdings plc
NASDAQ:MGTXBiotechnology
+$0.53 today
- Market cap
- $813.12M
- Beta
- 1.26
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$1.48
Volume 0.58M
Average 0.84M
MGTX Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
MeiraGTx Holdings plcNASDAQ: MGTX
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures grows, but more slowly than its trailing trend
Q1 FY2026 capital expenditures of $2.01M (cash outflow) rose 17.4% year over year, behind the +113.0% change in trailing-twelve-month capital expenditures. Sequentially, it fell 70.3% from the prior quarter. Over 3 fiscal years it compounded at -56.0% a year.
Context
- Capital expenditures amounted to 4.7% of revenue in FY2025, down 10.2 pp from a year earlier.
- Capital expenditures grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +17.4% toward the trailing-twelve-month pace of +113.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (3.83M) USD
- Year-over-year change
- +22.8%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.83M) | +22.8% |
| FY2024 | 2024-12-31 | (4.96M) | +75.4% |
| FY2023 | 2023-12-31 | (20.17M) | +55.1% |
| FY2022 | 2022-12-31 | (44.96M) | +18.6% |
| FY2021 | 2021-12-31 | (55.22M) | — |
Capital Expenditures vs competitors
How MGTX compares with its peers on the latest reported figures
- MGTX's LTM Mar 2026 capital expenditures of $10.62M is the 2nd largest of the 9 companies compared; the peer median is $539.5K.
- Its year-over-year change of +113.0% is the highest of 9, against a peer median of -83.5%.
- Capital expenditures amounts to 13.3% of revenue for MGTX, versus a peer median of 1.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $14.56M | +46.2% | -39.1% | 3.3% | |
| LTM Mar 2026 | $10.62M | +113.0% | -56.0% | 13.3% | |
| LTM Mar 2026 | $2.63M | -9.6% | -57.2% | 3.0% | |
| LTM Mar 2026 | $1.09M | -93.8% | -64.4% | — | |
| LTM Mar 2026 | $606K | -83.7% | -64.0% | 0.7% | |
| LTM Mar 2026 | $473K | -88.2% | -53.7% | 0.7% | |
| LTM Mar 2026 | $192K | -54.7% | +8.1% | 1.3% | |
| LTM Mar 2026 | $175K | -83.3% | -65.4% | 3.9% | |
| LTM Mar 2026 | $14K | -99.9% | -70.8% | 0.1% | |
| Peer median (excluding MGTX) | $539.5K | -83.5% | -60.6% | 1.3% | |
Competitors are the stored peer set for MGTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Depreciation & Amortization | 7.87M | 8.6M | 13.72M | 12.68M | 12.7M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 20.78M | 28.62M | 27.72M | 25.19M | 22.11M |
| Change in Working Capital | 31.28M | 9.62M | (983K) | 29.64M | 28.03M |
| Accounts Receivables | 16.7M | 5.17M | 4.83M | 9.43M | (7.27M) |
| Inventory | 0 | 0 | 0 | (387K) | 428K |
| Accounts Payables | 13.35M | 3.74M | 2.33M | 10.74M | (12.31M) |
| Other Working Capital | 1.23M | 713K | (8.14M) | 9.87M | 47.18M |
| Other Non-Cash Items | 9.1M | 9.67M | (61.8M) | (24.22M) | 5.01M |
| Operating Cash Flow | (10.53M) | (73.1M) | (105.37M) | (104.5M) | (46.36M) |
| Capital Expenditures | (55.22M) | (44.96M) | (20.17M) | (4.96M) | (3.83M) |
| Acquisitions (Net) | (6.5M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 54.21M | 28.43M | (281K) |
| Investing Cash Flow | (61.72M) | (44.96M) | 34.03M | 23.48M | (4.11M) |
| Debt Repayment | (1K) | 75M | 0 | 0 | (29K) |
| Common Stock Issued | 1.71M | 25M | 91.95M | 59.39M | 15.33M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (4.8M) | (7.93M) | (4.86M) | (3.03M) |
| Financing Cash Flow | 1.71M | 95.2M | 84.02M | 54.53M | 12.27M |
| Effect of Forex Changes | (1.28M) | 674K | 2.44M | 1.5M | 719K |
| Net Change in Cash | (71.82M) | (22.19M) | 15.13M | (24.98M) | (37.48M) |
| Free Cash Flow | (65.75M) | (118.06M) | (125.54M) | (109.45M) | (50.19M) |
MeiraGTx Holdings plc
NASDAQ:MGTX
Intrinsic Alpha fair value
Locked
Current Price
$8.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.